Here we focus on PSP, a primary tauopathy [1] characterised by the accumulation of 4-repeat tau in neuronal and glial cells, without the accumulation of beta-amyloid, as seen in Alzheimer’s disease, or alpha-synuclein, as seen in Parkinson’s disease. Here, MAPT is linked to supranuclear palsy, progressive, 1.